Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Grand Opening of the Second CREATE Symposium, Exploring New Directions in Smart Healthcare 2024-11-25 16:15
J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment 'JIN-001' - Enhancing Radiation and Chemotherapy Efficacy 2024-11-25 14:00
Smartee Introduces Facial Convexity and Deviation Solutions in Vietnam 2024-11-25 13:23
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy 2024-11-25 09:30
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors 2024-11-25 08:37
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024 2024-11-25 08:30
Novo AI's Solution Boosts APRIL International's Efficiency by 400% 2024-11-25 08:30
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection 2024-11-25 08:18
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024 2024-11-25 08:01
Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution 2024-11-23 21:00
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs 2024-11-23 05:09
International Genomics Conference (ICG-19) Opens at BGI Group HQ in Shenzhen 2024-11-22 21:57
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development 2024-11-22 21:30
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA 2024-11-22 19:34
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer 2024-11-22 16:00
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity 2024-11-22 12:14
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology 2024-11-22 10:27
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology 2024-11-22 10:15
United Imaging Announces the First of Several New U.S. Product Launches For RSNA 2024-11-22 03:00
TELUS Mental Health Index: Mental health of workers in Australia hits four-year low, costing businesses up to 69 workdays of productivity annually per employee 2024-11-22 02:00
1 2 3 4 5 962